Evidence map›Paper›PMID 16882984›Full record

ArticleGenes & development2006

E4F1: a novel candidate factor for mediating BMI1 function in primitive hematopoietic cells.

Jalila Chagraoui, Sherry L Niessen, Julie Lessard, Simon Girard, Philippe Coulombe, Martin Sauvageau, Sylvain Meloche, Guy Sauvageau

Open access · diamondAbstract read
In one paragraph

Article in Genes & development, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Glucocorticoid Receptor Binding Inhibits an IntronicInternational journal of molecular sciences · 2018
    Article
  11. Article
  12. Article
  13. Article
  14. E4F1-mediated control of pyruvate dehydrogenase activity is essential for skin homeostasis.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Jalila ChagraouiLaboratory of Molecular Genetics of Hematopoietic Stem Cells, Institut de Recherche en Immunologie et Cancérologie (IRIC), CP 6128 succursale Centre-Ville, Montréal, Québec, Canada.
Sherry L Niessen
Julie Lessard
Simon Girard
Philippe Coulombe
Martin Sauvageau
Sylvain Meloche
Guy Sauvageau
Institute for Research in Immunology and Cancer · CAHôpital Maisonneuve-Rosemont · CAUniversité de Montréal · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Polycomb group gene Bmi1 is essential for the proliferation of neural and hematopoietic stem cells. Much remains to be learned about the pathways involved in the severe hematopoietic phenotype observed in Bmi1 homozygous mutant mice except for the fact that loss of p53 or concomitant loss of p16(Ink4a) and p19(Arf) functions achieves only a partial rescue. Here we report the identification of E4F1, an inhibitor of cellular proliferation, as a novel BMI1-interacting partner in hematopoietic cells. We provide evidence that Bmi1 and E4f1 genetically interact in the hematopoietic compartment to regulate cellular proliferation. Most importantly, we demonstrate that reduction of E4f1 levels through RNA interference mediated knockdown is sufficient to rescue the clonogenic and repopulating ability of Bmi1(-/-) hematopoietic cells up to 3 mo post-transplantation. Using cell lines and MEF, we also demonstrate that INK4A/ARF and p53 are not essential for functional interaction between Bmi1 and E4f1. Together, these findings identify E4F1 as a key modulator of BMI1 activity in primitive hematopoietic cells.

Indexed as

Cell ProliferationAnimalsApoptosisCell CycleColony-Forming Units AssayCyclin-Dependent Kinase Inhibitor p16DNA-Binding ProteinsHematopoietic Stem CellsHumansImmunoprecipitationLiverMiceMice, KnockoutNuclear ProteinsPolycomb Repressive Complex 1Proto-Oncogene ProteinsBmi1 protein, mouseCyclin-Dependent Kinase Inhibitor p16DNA-Binding ProteinsE4f1 protein, mouseNuclear ProteinsPolycomb Repressive Complex 1Proto-Oncogene ProteinsRepressor ProteinsTranscription FactorsTumor Suppressor Protein p14ARFTumor Suppressor Protein p53Ubiquitin-Protein Ligases

Identifiers

PMID16882984
PMCPMC1536061
OpenAlexW2127124250

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.